entertainment -WSS

entertainment

author：comprehensive 2025-09-30 17:59:35 - browse：86587

Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation. — Suzanne Kreiter/Globe staff

WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Childhood cancer progress stalls for Black, Hispanic kids: Report

explore

WSS

Surge of respiratory disease in China has likely explanation

Poor hospice wound care hurts patients and families

After gene therapy, two congenitally deaf children hear for the first time

David Sabatini, ex

CDC wastewater surveillance dashboard to track bird flu hotspots

David Sabatini, ex

Wikipedia

entertainment

leisure time

Walensky prepares to leave CDC — and Congress — behind

Telehealth startups turn to complex chronic diseases

Medical records are filled with copy

Study: People of West African ancestry at greater risk of cardiac amyloidosis

Tori Bowie and the unacceptable rates of Black maternal death

Anthos stroke drug appears safer than common blood thinner

Sports medicine is finally prioritizing gender equality

How to improve immunocompromised access to mAb treatments

Medicare details structure of new drug price negotiation program

Does good food count as health care? Study aims to find out

explore

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

Wegovy, Zepbound and weight loss drugs that preserve muscle

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

World's first CRISPR

Steward Health Care files for bankruptcy

hotspot

leisure time

explore

focus